Cancer Research The Future of Cancer Research: Science and Patient Impact  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 50, 409-414, January 15, 1990]
© 1990 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nabi, I. R.
Right arrow Articles by Raz, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nabi, I. R.
Right arrow Articles by Raz, A.

Identification of B16-F1 Melanoma Autocrine Motility-like Factor Receptor

Ivan R. Nabi, Hideomi Watanabe and Avraham Raz1

Cancer Metastasis Program, Michigan Cancer Foundation Detroit, Michigan

B16-F1 melanoma cells express augmented glycosylation of a Mr 78,000 (gp78) cell surface glycoprotein in response to cell shape modulation which is correlated to an increased metastatic ability in vivo and motility in vitro. A monoclonal antibody (mAb) directed against gp78 was used to study its surface distribution and possible function in cell locomotion. On motile cells, gp78 is localized by immunofluorescence to the leading lamella as well as to the trailing edge, suggesting shuffling of gp78 during cell migration. When bound to the cells the mAb induced locomotory activity similar to the effect of the cells' autocrine motility-like factor (AMLF). The enhanced motility induced by either anti-gp78 mAb or autocrine motility factor (AMF) were both inhibited by pertussis toxin, indicating that the 3F3A mAb induces cell kinesis via the same pertussis toxin-sensitive G protein pathway as has been described for other motility factors. The binding of anti-gp78 mAb to its ligand was inhibited (10-fold) by preincubation with B16-F1 AMLF containing conditioned media. Based on such functional properties, it was concluded that gp78 behaves as an AMF receptor of the B16-F1 melanoma cell.

1 Supported by the Paul Zudermann Support Foundation for Cancer Research. To whom requests for reprints should be addressed.

Received 4/25/89. Revised 8/16/89. Accepted 10/11/89.




This article has been cited by other articles:


Home page
J. Cell Sci.Home page
J. G. Goetz, H. Genty, P. St-Pierre, T. Dang, B. Joshi, R. Sauve, W. Vogl, and I. R. Nabi
Reversible interactions between smooth domains of the endoplasmic reticulum and mitochondria are regulated by physiological cytosolic Ca2+ levels
J. Cell Sci., October 15, 2007; 120(20): 3553 - 3564.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. D. Kojic, B. Joshi, P. Lajoie, P. U. Le, M. E. Cox, D. A. Turbin, S. M. Wiseman, and I. R. Nabi
Raft-dependent Endocytosis of Autocrine Motility Factor Is Phosphatidylinositol 3-Kinase-dependent in Breast Carcinoma Cells
J. Biol. Chem., October 5, 2007; 282(40): 29305 - 29313.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
W. G. Jiang, A. Raz, A. Douglas-Jones, and R. E. Mansel
Expression of Autocrine Motility Factor (AMF) and Its Receptor, AMFR, in Human Breast Cancer
J. Histochem. Cytochem., February 1, 2006; 54(2): 231 - 241.
[Abstract] [Full Text] [PDF]


Home page
J Bone Joint Surg BrHome page
T. Kobayashi, H. Watanabe, T. Yanagawa, S. Tsutsumi, M. Kayakabe, T. Shinozaki, H. Higuchi, and K. Takagishi
Motility and growth of human bone-marrow mesenchymal stem cells during ex vivo expansion in autologous serum
J Bone Joint Surg Br, October 1, 2005; 87-B(10): 1426 - 1433.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
A. Lagana, J. G. Goetz, N. Y, Y. Altschuler, and I. R. Nabi
pH-specific sequestration of phosphoglucose isomerase/autocrine motility factor by fibronectin and heparan sulphate
J. Cell Sci., September 15, 2005; 118(18): 4175 - 4185.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. Tsutsumi, T. Yanagawa, T. Shimura, H. Kuwano, and A. Raz
Autocrine Motility Factor Signaling Enhances Pancreatic Cancer Metastasis
Clin. Cancer Res., November 15, 2004; 10(22): 7775 - 7784.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Amraei, Z. Jia, P. Reboul, and I. R. Nabi
Acid-induced Conformational Changes in Phosphoglucose Isomerase Result in Its Increased Cell Surface Association and Deposition on Fibronectin Fibrils
J. Biol. Chem., October 3, 2003; 278(40): 38935 - 38941.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
P. U. Le and I. R. Nabi
Distinct caveolae-mediated endocytic pathways target the Golgi apparatus and the endoplasmic reticulum
J. Cell Sci., March 15, 2003; 116(6): 1059 - 1071.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Tsutsumi, V. Hogan, I. R. Nabi, and A. Raz
Overexpression of the Autocrine Motility Factor/Phosphoglucose Isomerase Induces Transformation and Survival of NIH-3T3 Fibroblasts
Cancer Res., January 1, 2003; 63(1): 242 - 249.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. U. Le, G. Guay, Y. Altschuler, and I. R. Nabi
Caveolin-1 Is a Negative Regulator of Caveolae-mediated Endocytosis to the Endoplasmic Reticulum
J. Biol. Chem., January 25, 2002; 277(5): 3371 - 3379.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. Kara, Y. Ohta, Y. Tanaka, M. Oda, and Y. Watanabe
Autocrine motility factor receptor expression in patients with stage I non-small cell lung cancer
Ann. Thorac. Surg., March 1, 2001; 71(3): 944 - 948.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
H.-J. Wang, G. Guay, L. Pogan, R. Sauve, and I. R. Nabi
Calcium Regulates the Association between Mitochondria and a Smooth Subdomain of the Endoplasmic Reticulum
J. Cell Biol., September 18, 2000; 150(6): 1489 - 1498.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
P. Le, N Benlimame, A Lagana, A Raz, and I. Nabi
Clathrin-mediated endocytosis and recycling of autocrine motility factor receptor to fibronectin fibrils is a limiting factor for NIH-3T3 cell motility
J. Cell Sci., January 9, 2000; 113(18): 3227 - 3240.
[Abstract] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y.-J. Sun, C.-C. Chou, W.-S. Chen, R.-T. Wu, M. Meng, and C.-D. Hsiao
The crystal structure of a multifunctional protein: Phosphoglucose isomerase/autocrine motility factor/neuroleukin
PNAS, May 11, 1999; 96(10): 5412 - 5417.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
N. Benlimame, P. U. Le, and I. R. Nabi
Localization of Autocrine Motility Factor Receptor to Caveolae and Clathrin-independent Internalization of Its Ligand to Smooth Endoplasmic Reticulum
Mol. Biol. Cell, July 1, 1998; 9(7): 1773 - 1786.
[Abstract] [Full Text]


Home page
J. Histochem. Cytochem.Home page
I. R. Nabi, G. Guay, and D. Simard
AMF-R Tubules Concentrate in a Pericentriolar Microtubule Domain After MSV Transformation of Epithelial MDCK Cells
J. Histochem. Cytochem., October 1, 1997; 45(10): 1351 - 1364.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
H. Wang, N Benlimame, and I Nabi
The AMF-R tubule is a smooth ilimaquinone-sensitive subdomain of the endoplasmic reticulum
J. Cell Sci., January 12, 1997; 110(24): 3043 - 3053.
[Abstract] [PDF]


Home page
J. Cell Sci.Home page
G La Riviere, J. Klein Gebbinck, M. Driessens, and E Roos
Pertussis toxin inhibition of T-cell hybridoma invasion is reversed by manganese-induced activation of LFA-1
J. Cell Sci., January 3, 1994; 107(3): 551 - 559.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
C.-C. Chou, Y.-J. Sun, M. Meng, and C.-D. Hsiao
The Crystal Structure of Phosphoglucose Isomerase/Autocrine Motility Factor/Neuroleukin Complexed with Its Carbohydrate Phosphate Inhibitors Suggests Its Substrate/Receptor Recognition
J. Biol. Chem., July 21, 2000; 275(30): 23154 - 23160.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1990 by the American Association for Cancer Research.